Version 3 of 3 (2007-07-04 to 2008-04-28) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
Corporation: |
Vacci-Test Corporation
#1005, 550 - 11th Ave SW Calgary, AB T2R 1M7 Canada |
Telephone number: | 403-269-9424 |
Fax number: | 403-263-6357 |
Responsible officer name and position during the period of this registration: | William J. Hogan, President & CEO |
Description of activities: | Vacci-Test Corporation is a private Alberta biotechnology corp. whose objective is to perfect, adapt and commercialize the patented Vacci-Test technology, which are rapid and economical diagnostic tests for identifying infectious diseases both bacterial and viral. Intended for use in both human and veterinary medicine, Vacci-Test products were researched, developed and manufactured by partnered companies in Europe and will be commercialized by Vacci-Test initially in Canada, the U.S., Mexico and Europe. |
Parent: | The corporation is not a subsidiary of any other parent corporations. |
Coalition | The corporation is not a member of a coalition. |
Subsidiary: | The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking. |
Other direct interests | The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking. |
Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
Name: | William Hogan |
Position title: | President & CEO |
Public offices held: | No |
Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Agriculture and Agri-Food Canada (AAFC), Canadian International Development Agency (CIDA), Farm Products Council of Canada (FPCC), Foreign Affairs and International Trade Canada (DFAITC), Hazardous Materials Information Review Commission (HMIRC), Health Canada (HC), Members of the House of Commons, Prime Minister's Office (PMO), Privy Council Office (PCO), Western Economic Diversification Canada (WD) | ||||||
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format | ||||||
Subject Matter: Areas of Concern: | Government Procurement, Health, Intellectual Property, Science and Technology | ||||||
Subject Matter: Retrospective: | To date no contact has been made with the Federal Government. | ||||||
Subject Matter: Prospective: | None anticipated for the next six months. | ||||||
Details Regarding the Identified Subject Matter
|